Bioavailability of bioactive compounds in foods
DOI:
https://doi.org/10.17533/udea.penh.19001Keywords:
Bioactive compounds, phytochemicals, biological availability, metabolism, xenobiotics, foodsAbstract
Background: The knowledge of bioactive phytochemicals contained in foods, which may exert beneficial health effects, is of great importance in current nutrition. Bioactive phytochemicals must reach the tissues in which they act through the blood circulation, and their bioavailability depends on various factors. Aim: To describe some relevant issues related with the determination of the bioavailability of bioactive compounds, a major factor that determines their capacity to exert beneficial effects. Methodology: Some basic aspects of the determination of the bioavailability of bioactive food components are described, and key issues to understand the results observed are discussed, based on relevant bibliographic resources Thomson, Scielo databases and edited books. Results: Bioavailability constitutes a useful tool to know if bioactives in foods are able to reach the body systems on which they exert their beneficial effects. Bioavailability is dependent on various factors, including the physiology of the subject, the food matrix, and even the type of intestinal microbiota. Conclusion: The traditional methods used to determine bioavailability, that include plasmatic and urinary levels of the bioactive molecules in foods, should take into consideration a variety of factors in order to make an adequate interpretation of the results.
Downloads
References
Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, et al. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst. 2004;96:1577-84.
He FJ, Nowson CA, Lucas M, MacGregor GA. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hypertension. 2007;21:717-28.
Erdman JW, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, et al. Flavonoids and heart health. Proceedings of the ILSI North America Flavonoids Workshop 2005. J Nutr. 2007;137:718S-37S.
Crowe FL, Roddam AW, Key TJ, Appleby PN, Overad K, Jakobsen MU, et al. Fruit and vegetable intake and mortality from ischemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart Study. Eur Heart J. 2011;32:1235-43.
Buttriss J. Phytonutrients. In: Salter A, Wiseman HJ, Tucker G, eds. New York: Blackwell Publishing Ltd; 2012.
Holst B, Williamson G. Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr Opin Biotechnol. 2008;19:73-82.
Epriliati I, Ginjom IR. Bioavailability of phytochemicals. In: Phytochemicals: a global perspective of their role in nutrition and health. Rijeka, Croatia: InTech; 2011; p. 401-28.
Williamson G. The use of flavonoid aglycones in in vitro systems to test biological activities: based on bioavailability data, is this a valid approach? Phytochem Rev. 2003;1:215-22.
Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr. 2005;81(suppl):243S-55S.
Hu M. Commentary: Bioavailability of flavonoids and polyphenols, call to arms. Molec Pharm. 2007;4:803-6.
Fernández-García E, Carvajal-Lérida I, Jarén-Galán M, Garrido-Fernández J, Pérez-Gálvez A, Hornero-Méndez D. Carotenoids bioavailability from foods: From plant pigments to efficient biological activities. Food Res Internat. 2012;46:438-50.
Deming DM, Erdman JW. Mammalian carotenoid absorption and metabolism. Pure Appl Chem. 1999;71:2213-33.
Bravo L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998;56:317-33.
Stevenson DE, Hurst RD. Polyphenolic phytochemicals – just antioxidants or much more? Cell Mol Life Sci. 2007;64:2900-16.
Parada J, Aguilera JM. Food microstructure affects the bioavailability of several nutrients. J Food Sci. 2007;72:R21-R32.
Scholz S, Williamson G. Interactions affecting the bioavailability of dietary polyphenols in vivo. Int J Vitam Nutr Res. 2007;77:224-35.
Yang M, Koo SI, Song WO, Chun OK. Food matrix affecting anthocyanin bioavailability: Review. Curr Med Chem. 2011;18:291-300.
Wang L, Bohn T. Health-promoting food ingredients and functional food processing. In: Nutrition, well-being and health. Rijeka, Croatia: InTech; 2012; p. 201-224.
Schramm DD, Karim M, Schrader HR, Holt RR, Kirkpatrick NJ, Polagruto JA, et al. Food effects on the absorption and pharmacokinetics of cocoa flavanols. Life Sci. 2003;73:857-69.
Neilson AP, Sapper TN, Janle EM, Rudolph R, Matusheski NV, Ferruzzi MG. Chocolate matrix factors modulate the pharmacokinetic behavior of cocoa flavan-3-ol phase II metabolites following oral consumption by Sprague-Dawley rats. J Agric Food Chem. 2010;58:6685-91.
Borges G, Mullen W, Mullan A, Lean MEJ, Roberts SA, Crozier A. Bioavailability of multiple components following acute ingestion of a polyphenols-rich juice drink. Mol Nutr Food Res. 2010;54:S268-77.
Palafox-Carlos H, Ayala-Zavala JF, González-Aguilar GA. The role of dietary fiber in the bioaccesibility and bioavailability of fruit and vegetable antioxidants. J Food Sci. 2011;76:R6-R15.
Lutz M. Lípidos de la dieta: participación en el metabolismo de xenobióticos. Anal Univer Chile. 2000;11:143-55.
Williamson G, Barron D, Shimoi K, Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res. 2005;39:457-69.
Forester SC, Waterhouse AL. Metabolites are key to understanding health effects of wine polyphenolics. J Nutr. 2009;138:1824S-31S.
Day AJ, Cañada FJ, Díaz JC, Kroon PA, Mclaughlan R, Faulds CB, et al. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase-phlorizin-hydrolase. FEBS Lett. 2000;468:166-70.
Nemeth K, Plumb GW, Berrin JG, Juge R, Naim HY, Williamson G, et al. Deglycosylation by human intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr. 2003;42:29-42.
Aura AM. Microbial metabolism of dietary phenolic compounds in the colon. Phytochem Rev. 2008;7:407-29.
Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000;130:2073S-85S.
Lampe JW, Chang JL. Interindividual differences in phytochemical metabolism and disposition. Semin Cancer Biol. 2007;17:347-53.
Cerda B, Tomás Barberán FA, Espín JC. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: Identification of biomarkers and individual variability. J Agric Food Chem. 2005; 53:227-35.
Selma MV, Espín JC, Tomás-Barberán FA. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem. 2009;57:6485-6501.
Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr. 2008;138:1244S-9S.
Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol: a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-84.
Rafii F, Davis C, Park M, Heinze TM, Berger RD. Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals. Arch Microbiol. 2003;180:11-6.
Lutz M. Soy isoflavones as bioactive ingredients of functional foods. In: Soybean and health. Rijeka, Croatia: InTech; 2011. p. 329-60.
Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81:230S-42S.
Del Rio D, Costa LG, Lean MEJ, Crozier A. Polyphenols and health: What compounds are involved?. Nutr Metab Cardiovasc Dis. 2010; 0:1-6.
Verzelloni E, Pellacani C, Tagliazucchi D, Tagliaferri S, Calani L, Costa LG, et al. Antiglycative and neuroprotective activity of colon derived polyphenol catabolites. Mol Nutr Food Res. 2011;55:S35-43.
Mastan S, Bhavya Latha T, Ajay S. The basic regulatory considerations and prospects for conducting bioavailability/bioequivalence (BA/BE) studies–an overview. Comp Effectiveness Res. 2011;1:1-25.
Mullen W, Edwards CA, Crozier A. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr. 2006;96:107-16.
Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Therap. 2002;96:67-202.
Larrosa M, Luceri C, Vivoli E, Pagliuca C, Lodovici M, Moneti G, et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol Nutr Food Res. 2009;53:1044-54.
Crozier A, Burns J, Aziz AA, Stewart A, Rabiasz HS, Jenkins GI, et al. Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability. Biol Res. 2000;33:79-88.
Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2:270-78.
Aziz AA, Edwards CA, Lean MEJ, Crozier A. Absorption and excretion of conjugated flavonols, including quercetin-4’-Obeta-glucoside and isorhamnetin-4’-O-beta-glucoside by human volunteers after the consumption of onions. Free Radic Res.1998;29:257-69.
Hollman PCH, Vries JHM, Leeuwen SD, Mengelers MJB, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr. 1995;62:1276-82.
Hollman PCH. Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol. 2004;42:74-83.
Stalmach A, Edwards CA, Wightman JD, Crozier A. Identification of (Poly)phenolic compounds in Concord grape juice and their metabolites in human plasma and urine after juice consumption. J Agric Food Chem. 2011;59:9512-22.
Lutz M, Jorquera K, Cancino B, Ruby R, Henríquez C. Phenolics and antioxidant capacity of table grape (Vitis vinifera L.) cultivars grown in Chile. J Food Sci. 2011;76:C1088-93.
Lutz M, Castro E, García L, Henríquez C. Bioavailability of phenolic compounds from grape juice cv Autumn Royal. J Food CyTA. 2013. doi: 10.1080/19476337.2013.793213.
Chandhuri S, Banerjee A, Basu K, Sengupta B, Sengupta PK. Interaction of flavonoids with red blood cell membrane lipids and proteins: antioxidant and antihemolitic effects. Int J Biol Macromol. 2007;41:42-48.
Biasutto L, Marotta E, Garbisa S, Zoratti M, Paradisi C. Determination of quercetin and resveratrol in whole blood–Implications for bioavailability studies. Molecules. 2010;15:6570-9.
Crews H, Alink G, Andersen R, Braesco V, Holst B, Maiani G, et al. A critical assessment of some biomarker approaches linked with dietary intake. Br J Nutr. 2001;86 (Suppl.1):S5-35.
Kussmann M, Affolter M, Nagy K, Holst B, Fay LB. Mass spectrometry in nutrition: understanding dietary health effects at the molecular level. Mass Spectrom Rev. 2007;26:727-50.
German JB, Hammock BD, Watkins SM. Metabolomics: building on a century of biochemistry to guide human health. Metabolomics.2005;1:3-8.
